Latest Updates
Read the latest news that impacts the oncology community.
340B could have a new cop on the beat. Hospitals are worried.
The Trump administration is pushing significant changes to the healthcare status quo that it says will save money, improve oversight and make the $4.9 trillion sector more efficient.
Read MoreSurprise Medical Bills Were Supposed To Be a Thing of the Past. Surprise — They’re Not.
Last year in Massachusetts, after finding lumps in her breast, Jessica Chen went to Lowell General Hospital-Saints Campus, part of Tufts Medicine, for a mammogram and sonogram.
Read MoreExperts Weigh In on What FDA's Removal of REMS for CAR T Means for Patients, Pharmacists
In an interview with Pharmacy Times®, Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology and vice president of the Community Oncology Alliance, and Houston Holmes, MD, a physician at Texas Oncology with specialties in hematologic malignancies, discussed the FDA’s decision to eliminate Risk Evaluation and Mitigation Strategies (REMS) requirements for BCMA- and CD19-directed chimeric antigen receptor (CAR) T-cell (CAR T) therapies.
Read MoreBuilding a Better Future Through Technology, Advocacy, and Community
Each year at the American Society of Clinical Oncology (ASCO) Annual Meeting, leading scientists present the latest findings from clinical trials, offering hope of continuing life, reducing harsh effects of therapy, or both.
Read MoreHow the U.S. health care system fails cancer patients like former MTV VJ Ananda Lewis
When I read that Ananda Lewis had died of breast cancer, I felt a deep, familiar heartbreak, followed by a sharper, more painful recognition: This didn’t have to happen.
Read MoreOncologists need to see antimicrobial resistance as a cancer care delivery crisis
As a medical oncologist, one of the first threats I inform new patients about during the informed consent process for cancer treatment is how vulnerable they now are to infections.
Read MoreFor Community Oncology, Good News in PFS Offset by Potential Wreckage of MFP Proposal
The 2026 Physician Fee Schedule (PFS), proposed Monday by CMS, offers proof that regulators are listening at last to pleas from community oncology practices to even the playing field with hospitals.1
Read MoreUnitedHealth is composed of nearly 2,700 subsidiaries: 10 notes
A new, first-of-its-kind report details the corporate structure and acquisition history of the world’s largest healthcare company, UnitedHealth Group.
Read MoreThis Week in 340B: July 8 – 14, 2025
Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation.
Read MoreWhat’s going on with 340B? [Part 2] Compliance and oversight
For 340B covered healthcare entities, complying with the federal drug pricing program’s specific regulations and passing regulatory audits by the Health Resources & Support Administration (HRSA) is only the tip of the iceberg.
Read More